Evidence map›Paper›PMID 27411687›Full record

ArticleJournal of mammary gland biology and neoplasia2016

p120-Catenin Is Critical for the Development of Invasive Lobular Carcinoma in Mice.

Milou Tenhagen, Sjoerd Klarenbeek, Tanya M Braumuller, Ilse Hofmann, Petra van der Groep, Natalie Ter Hoeve, Elsken van der Wall, Jos Jonkers, Patrick W B Derksen

Open access · hybridAbstract read
In one paragraph

Article in Journal of mammary gland biology and neoplasia, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Functions of p120-catenin in physiology and diseases.Frontiers in molecular biosciences · 2024
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Milou TenhagenDepartment of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Sjoerd KlarenbeekDivision of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Tanya M BraumullerDivision of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Ilse HofmannVascular Oncology and Metastasis, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Petra van der GroepDepartment of Medical Oncology, Cancer Center, UMC Utrecht, Utrecht, The Netherlands.
Natalie Ter HoeveDepartment of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Elsken van der WallDepartment of Medical Oncology, Cancer Center, UMC Utrecht, Utrecht, The Netherlands.
Jos JonkersDivision of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Patrick W B DerksenDepartment of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. pderksen@umcutrecht.nl.
University Medical Center Utrecht · NLThe Netherlands Cancer Institute · NLOncode Institute · NLUniversity Hospital Heidelberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Loss of E-cadherin expression is causal to the development of invasive lobular breast carcinoma (ILC). E-cadherin loss leads to dismantling of the adherens junction and subsequent translocation of p120-catenin (p120) to the cytosol and nucleus. Although p120 is critical for the metastatic potential of ILC through the regulation of Rock-dependent anoikis resistance, it remains unknown whether p120 also contributes to ILC development. Using genetically engineered mouse models with mammary gland-specific inactivation of E-cadherin, p120 and p53, we demonstrate that ILC formation induced by E-cadherin and p53 loss is severely impaired upon concomitant inactivation of p120. Tumors that developed in the triple-knockout mice were mostly basal sarcomatoid carcinomas that displayed overt nuclear atypia and multinucleation. In line with the strong reduction in ILC incidence in triple-knockout mice compared to E-cadherin and p53 double-knockout mice, no functional redundancy of p120 family members was observed in mouse ILC development, as expression and localization of ARVCF, p0071 or δ-catenin was unaltered in ILCs from triple-knockout mice. In conclusion, we show that loss of p120 in the context of the p53-deficient mouse models is dominant over E-cadherin inactivation and its inactivation promotes the development of basal, epithelial-to-mesenchymal-transition (EMT)-type invasive mammary tumors.

Indexed as

AnimalsCadherinsCarcinoma, LobularCateninsCell NucleusCytosolDelta CateninFemaleMammary Neoplasms, ExperimentalMiceMice, KnockoutNeoplasm InvasivenessTumor Suppressor Protein p53CadherinsCateninsCtnnd1 protein, mouseDelta CateninTumor Suppressor Protein p53Breast cancerInvasive lobular carcinomaMouse modelp120

Identifiers

PMID27411687
PMCPMC5159444
OpenAlexW2467257085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.